PHARMACOLOGICAL SYNERGY BETWEEN HIGH-DOSE ARA-C (HIDAC) AND MITOXANTRONE (MIT) IN MURINE LEUKEMIA L5178Y

被引：0
|
作者：
WANG, LM [1 ]
CAPIZZI, RL [1 ]
CONTENTO, M [1 ]
DIMLING, J [1 ]
机构：
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,ONCOL RES CTR,WINSTON SALEM,NC 27103
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1986年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [41] TOXICITY OF SEQUENTIAL HIGH-DOSE ARA-C ASPARAGINASE TREATMENT IN CHILDHOOD POOR RISK LEUKEMIA
    GRUMAYER, ER
    SCHMIDMEIER, W
    PANZER, S
    GADNER, H
    BLUT, 1986, 53 (04): : 309 - 314
  • [42] CONTINUOUS INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN REFRACTORY PEDIATRIC LEUKEMIA
    OCHS, JJ
    LOOK, AT
    SINKULE, J
    KALWINSKY, D
    DANKS, M
    BOWMAN, WP
    RIVERA, G
    SIMONE, JV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 159 - 159
  • [43] ALTERATION OF THE PHARMACOKINETICS OF HIGH-DOSE ARA-C BY ITS METABOLITE, HIGH ARA-U IN PATIENTS WITH ACUTE-LEUKEMIA
    CAPIZZI, RL
    YANG, JL
    CHENG, E
    BJORNSSON, T
    SAHASRABUDHE, D
    TAN, RS
    CHENG, YC
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) : 763 - 771
  • [44] TREATMENT OF REFRACTORY AND RECIDIVIST ACUTE MYELOID-LEUKEMIA WITH HIGH-DOSE ARA-C AND AMSACRINE
    KALHS, P
    KOS, M
    JAGER, U
    SCHWARZINGER, I
    BETTELHEIM, P
    PANZER, S
    HINTERBERGER, W
    NEUMANN, E
    LECHNER, K
    ONKOLOGIE, 1987, 10 (05): : 279 - 280
  • [45] VITAMIN-A AND OR HIGH-DOSE ARA-C IN THE MAINTENANCE OF REMISSION IN ACUTE MYELOGENOUS LEUKEMIA IN CHILDREN
    LIE, SO
    SLORDAHL, SH
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1984, 33 (03): : 256 - 259
  • [46] Phase I trial of the PKC activator/downregulator bryostatin 1 (NSC 339555) and high-dose Ara-C (HiDAC) in patients with refractory acute leukemia.
    Grant, S
    Cragg, L
    Roberts, J
    Andreef, M
    Feldman, E
    Winning, M
    Tombes, M
    BLOOD, 1999, 94 (10) : 509A - 509A
  • [47] A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Christian, Sonia
    Patel, Pritesh
    Esen, Aysenur
    Khan, Irum
    Sweiss, Karen
    Ghanem, Fares
    Sequeira, Christopher A.
    Shergill, Ardaman
    Quigley, John G.
    BLOOD, 2017, 130
  • [48] A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia
    Rosen, PJ
    Rankin, C
    Head, DR
    Boldt, DH
    Luthardt, FW
    Norwood, T
    Pugh, RP
    Karanes, C
    Appelbaum, FR
    LEUKEMIA RESEARCH, 2000, 24 (03) : 183 - 187
  • [49] HIGH-DOSE ARA-C (HIDAC) PLUS ASPARAGINASE IN ELDERLY PATIENTS WITH ACUTE NON-LYMPHOCYTIC LEUKEMIA - A PILOT MULTICENTRIC STUDY BY THE ITALIAN COOPERATIVE GROUP GIMEMA
    PETTI, MC
    MANDELLI, F
    AVVISATI, G
    COVELLI, A
    AMADORI, S
    LISO, V
    LEONE, G
    DELAURENZI, A
    LEONI, P
    NERI, A
    GRIGNANI, F
    TORLONTANO, G
    DERIU, L
    CARONIA, F
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 42 (01) : 24 - 31
  • [50] PHASE-II TRIAL OF HIGH-DOSE ARA-C (HIDAC) AND CISPLATIN (CDDP) FOR RECURRENT SQUAMOUS CARCINOMA OF THE HEAD AND NECK (SCHN)
    POWELL, BL
    CRAIG, JB
    MUSS, HB
    ZEKAN, PJ
    CRUZ, JM
    COOPER, MR
    GRIMM, RA
    BOBZIEN, WF
    BROWN, RC
    RAAB, SO
    WHITE, DR
    CAPIZZI, RL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 215 - 215
12345